These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
127 related articles for article (PubMed ID: 5321111)
21. Induction of specific autoimmune response to leukaemic cells in human leukaemia patient by chemically tagged normal "O" group white blood cells. Sahasrabudhe MB; Madyastha KR; Prema S; Lele RD; Gollerkeri MP; Rao SS Nature; 1971 Jul; 232(5307):198-9. PubMed ID: 4997380 [No Abstract] [Full Text] [Related]
22. [Immunocytologic identification of blood group substances in blood and bone marrow smears--its usefulness in bone marrow transplantation and leukemia]. Manabe S; Yamada M; Mori S; Kodo H; Asano S; Miwa S Rinsho Byori; 1985 Oct; 33(10):1124-8. PubMed ID: 3910861 [No Abstract] [Full Text] [Related]
23. [Immunotherapy of acute leukoses]. Krepler P Krebsarzt; 1969; 24(4):208-20. PubMed ID: 4190048 [No Abstract] [Full Text] [Related]
27. Heterotransplantability of human cell lines derived from leukemia and lymphomas into immunologically tolerant rats. Southam CM; Burchenal JH; Clarkson B; Tanzi A; Mackey R; McComb V Cancer; 1969 Aug; 24(2):211-22. PubMed ID: 4894370 [No Abstract] [Full Text] [Related]
28. Leukocyte transfusions: function of transfused granulocytes from donors with chronic myelocytic leukemia. Eyre HJ; Goldstein IM; Perry S; Graw RG Blood; 1970 Oct; 36(4):432-42. PubMed ID: 5271808 [No Abstract] [Full Text] [Related]
29. Transfusion requirements after bone marrow transplantation from HLA-identical siblings: effects of donor-recipient ABO incompatibility. Mehta J; Powles R; Singhal S; Horton C; Hamblin M; Zomas A; Saso R; Treleaven J Bone Marrow Transplant; 1996 Jul; 18(1):151-6. PubMed ID: 8832008 [TBL] [Abstract][Full Text] [Related]
30. [Loss of leukocyte AB blood group antigens in 2 patients with leukemia]. Májský A Blut; 1968 Dec; 18(3):172-4. PubMed ID: 5249534 [No Abstract] [Full Text] [Related]
31. ABO incompatibility as an adverse risk factor for survival after allogeneic bone marrow transplantation. Benjamin RJ; McGurk S; Ralston MS; Churchill WH; Antin JH Transfusion; 1999 Feb; 39(2):179-87. PubMed ID: 10037129 [TBL] [Abstract][Full Text] [Related]
32. Active immunization of children suffering from acute leukaemia in acute phase with "live" allogeneic leukaemic cells. Skurkovich SV; Kisljak NS; Machonova LA; Begunenko SA Nature; 1969 Aug; 223(5205):509-11. PubMed ID: 5256265 [No Abstract] [Full Text] [Related]
33. A double buffy coat method for red cell removal from ABO-incompatible marrow. Rosenfeld CS; Tedrow H; Boegel F; Gremba C; Shadduck RK Transfusion; 1989 Jun; 29(5):415-7. PubMed ID: 2660336 [TBL] [Abstract][Full Text] [Related]
37. Graft-versus-host disease and survival after ABO-incompatible allogeneic bone marrow transplantation: a single-centre experience. Stussi G; Seebach L; Muntwyler J; Schanz U; Gmür J; Seebach JD Br J Haematol; 2001 Apr; 113(1):251-3. PubMed ID: 11328309 [TBL] [Abstract][Full Text] [Related]
38. Human marrow transplantation--current status. Buckner CD; Clift RA; Fefer A; Neiman P; Storb R; Thomas ED Prog Hematol; 1973; 8():299-324. PubMed ID: 4150971 [No Abstract] [Full Text] [Related]
39. Allogeneic bone marrow transplantation in leukemia. Kolb HJ Recent Results Cancer Res; 1984; 93():269-89. PubMed ID: 6382484 [No Abstract] [Full Text] [Related]
40. [Investigations on the antigenic specificity of leukocytes in acute or chronic leukemias]. Berceanu S; Stoichita M; Gheorghiu-Teican M; Iamandi I Bibl Haematol; 1965; 23():185-91. PubMed ID: 5220456 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]